Word: merck
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...conservative groups met with representatives from Merck, the vaccine manufacturer, which among other things presented evidence at the CDC hearings that there was no data linking access to the vaccine with increases in sexual behavior. "We did what we ordinarily do when we are prepared to launch a vaccine," says Merck spokesperson Kelley Dougherty. "We met with physicians, consumer groups and in this case faith-based organizations, to talk about what the disease looks like, what the vaccine does; it was part of a broad communications strategy." Merck also launched an ad campaign, "Tell Someone," that aims to teach viewers...
...cancer-fighting vaccine, designed to protect women from four strains of the human papilloma virus (HPV), two of which are believed to cause 70% of cervical-cancer cases; for females aged 9 to 26; by the U.S. Food and Drug Administration; in Maryland. The drug, produced by pharmaceutical giant Merck & Co., is the first to attempt to prevent infections that can develop into cervical cancer, which each year kills as many as 233,000 women worldwide...
Gardasil offers nearly 100% protection against the two most common cancer-causing HPV strains, as well as two others that cause genital warts. But at $360 for three shots given over six months, the vaccine, which was developed by Merck, is among the most expensive on the market. The price tag alone probably puts it out of reach for many uninsured women in the U.S. (as well as those whose insurance companies balk at the cost), not to mention millions of poor women in the developing world, where cervical cancer is a leading cause of death. The Gates Foundation announced...
With the approval of Merck's vaccine against cervical cancer Thursday, parents will soon be having some important and touchy conversations with their young daughters - about...
...Harvard Medical School (HMS) biochemist’s research on a common cause of blindness in the elderly has generated a lucrative deal with Merck & Co., the US’s second-largest drug provider. Pfeiffer Professor of Biological Chemistry and Molecular Pharmacology Robert R. Rando’s research has paved the way for the manufacturing of drugs that might combat the progression of dry age-related macular degeneration (AMD), the most common version of AMD which causes vision loss in up to eight million American elderly a year. Merck will pay an initial $3 million, along with later...